Registration
BGR GOVERNMENT AFFAIRS for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide guidance and strategic counsel with regard related to orphan drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOYER New | Sp Asst to Sec HHS, Con Asst, Off of WH Liaison DoD ; ; Sp Asst Pres LA, Asst Comm Leg, FDA |
| ROBERT WOOD New | Chief of Staff to HHS Secretary |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TAKEDA PHARMACEUTICALS COMPANY LIMITED | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.